These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26786161)

  • 21. Idol Depletion Protects against Spontaneous Atherosclerosis in a Hamster Model of Familial Hypercholesterolemia.
    Liang C; Wang X; Peng K; Lai P; Liu Z; Ma J; Chen X; Liu G; Zheng M; Wang Y; Yang H; Liu G; Xian X; Gao M
    Oxid Med Cell Longev; 2022; 2022():1889632. PubMed ID: 35656026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
    Scotti E; Calamai M; Goulbourne CN; Zhang L; Hong C; Lin RR; Choi J; Pilch PF; Fong LG; Zou P; Ting AY; Pavone FS; Young SG; Tontonoz P
    Mol Cell Biol; 2013 Apr; 33(8):1503-14. PubMed ID: 23382078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.
    Sorrentino V; Nelson JK; Maspero E; Marques ARA; Scheer L; Polo S; Zelcer N
    J Lipid Res; 2013 Aug; 54(8):2174-2184. PubMed ID: 23733886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platycodin D enhances LDLR expression and LDL uptake via down-regulation of IDOL mRNA in hepatic cells.
    Choi YJ; Lee SJ; Kim HI; Lee HJ; Kang SJ; Kim TY; Cheon C; Ko SG
    Sci Rep; 2020 Nov; 10(1):19834. PubMed ID: 33199761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression.
    Dong B; Wu M; Cao A; Li H; Liu J
    Int J Mol Med; 2011 Jan; 27(1):103-10. PubMed ID: 21069265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting saposin-like protein (Msap).
    Do HT; Tselykh TV; Mäkelä J; Ho TH; Olkkonen VM; Bornhauser BC; Korhonen L; Zelcer N; Lindholm D
    J Biol Chem; 2012 Apr; 287(16):12602-11. PubMed ID: 22378787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use of L-sIDOL Transgenic Mice as a Murine Model to Study Hypercholesterolemia and Atherosclerosis.
    Zerenturk EJ; Calkin AC
    Methods Mol Biol; 2017; 1583():65-72. PubMed ID: 28205167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The E3 ubiquitin ligase inducible degrader of the LDL receptor/myosin light chain interacting protein in health and disease.
    van Loon NM; Lindholm D; Zelcer N
    Curr Opin Lipidol; 2019 Jun; 30(3):192-197. PubMed ID: 30896554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.
    Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ
    Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis.
    Choi J; Gao J; Kim J; Hong C; Kim J; Tontonoz P
    Sci Transl Med; 2015 Nov; 7(314):314ra184. PubMed ID: 26582899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation.
    Huang Y; Liu FY; Yang JT; Zhao Q; Zhu MQ; Wang J; Long SY; Tuo QH; Zhang CP; Lin LM; Liao DF
    Eur J Pharmacol; 2024 Mar; 966():176352. PubMed ID: 38290567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of the E3 Ubiquitin Ligase IDOL Attenuates Diet-Induced Obesity and Metabolic Dysfunction in Mice.
    van Loon NM; Ottenhoff R; Kooijman S; Moeton M; Scheij S; Roscam Abbing RLP; Gijbels MJJ; Levels JHM; Sorrentino V; Berbée JFP; Rensen PCN; Zelcer N
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1785-1795. PubMed ID: 29903737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xanthohumol Suppresses Mylip/Idol Gene Expression and Modulates LDLR Abundance and Activity in HepG2 Cells.
    Chen SF; Chen PY; Hsu HJ; Wu MJ; Yen JH
    J Agric Food Chem; 2017 Sep; 65(36):7908-7918. PubMed ID: 28812343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.
    Zhang L; Fairall L; Goult BT; Calkin AC; Hong C; Millard CJ; Tontonoz P; Schwabe JW
    Genes Dev; 2011 Jun; 25(12):1262-74. PubMed ID: 21685362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation.
    Pietiäinen V; Vassilev B; Blom T; Wang W; Nelson J; Bittman R; Bäck N; Zelcer N; Ikonen E
    J Cell Sci; 2013 Sep; 126(Pt 17):3961-71. PubMed ID: 23813961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.
    Calkin AC; Goult BT; Zhang L; Fairall L; Hong C; Schwabe JW; Tontonoz P
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20107-12. PubMed ID: 22109552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor.
    Zhang L; Xu M; Scotti E; Chen ZJ; Tontonoz P
    J Lipid Res; 2013 May; 54(5):1410-20. PubMed ID: 23419260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia.
    Chan ML; Shiu SW; Cheung CL; Yu-Hung Leung A; Tan KC
    Endocr Connect; 2022 Jun; 11(6):. PubMed ID: 35560019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population.
    Dhyani A; Tibolla G; Baragetti A; Garlaschelli K; Pellegatta F; Grigore L; Norata GD; Catapano AL
    PLoS One; 2015; 10(4):e0122414. PubMed ID: 25927920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNF130 Regulates LDLR Availability and Plasma LDL Cholesterol Levels.
    Clifford BL; Jarrett KE; Cheng J; Cheng A; Seldin M; Morand P; Lee R; Chen M; Baldan A; de Aguiar Vallim TQ; Tarling EJ
    Circ Res; 2023 Mar; 132(7):849-863. PubMed ID: 36876496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.